-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical Network News, April 19 Since April 16, pharmacies in Shanxi Province have resumed sales of antipyretic drugs.
With immediate effect, pharmacies resume sales
According to the "Notice on Strictly Implementing the Requirements for Suspending the Sale of Antipyretic Drugs During the Period of Epidemic Prevention and Control" issued by the Shanxi Provincial Food and Drug Administration at the beginning of this year, retail pharmacies should immediately suspend the sale of antipyretic drugs to the public after receiving the notice, and make an inventory.
Off the shelf.
Off the shelf.
Today, sales of antipyretic drugs in retail pharmacies in Shanxi Province have finally recovered.
On April 15, the Shanxi Provincial Drug Administration issued the "Notice on Lifting the Control Measures for the Suspension of Sales of Antipyretic Drugs" (hereinafter referred to as the "Notice").
On April 15, the Shanxi Provincial Drug Administration issued the "Notice on Lifting the Control Measures for the Suspension of Sales of Antipyretic Drugs" (hereinafter referred to as the "Notice").
According to the "Notice", according to the requirements of the "Response of the Office of the Leading Group for the Prevention and Control of the Novel Coronavirus Pneumonia Epidemic of Shanxi Province on Lifting the Suspension of Sales of Antipyretic Drugs", the epidemic prevention and control measures will be dynamically adjusted, starting from April 16, 2021 Since the start, the province’s drug retail companies have lifted the control measures for the suspension of sales of antipyretic drugs.
In accordance with the requirements of the "Notice", retail pharmacies must do a good job in registering the sales information of antipyretic drugs across the province.
When pharmaceutical retail enterprises in the province sell antipyretic drugs (the catalogue in the document of the Shanxi Epidemic Prevention and Control Office [2021] No.
28 is still implemented), they should be listed in the Shanxi Government Sanjintong Mini Program "Antipyretic Drug Sales Registration Information System", Register the drug-related information to ensure that the registered information is complete, true and effective.
When pharmaceutical retail enterprises in the province sell antipyretic drugs (the catalogue in the document of the Shanxi Epidemic Prevention and Control Office [2021] No.
28 is still implemented), they should be listed in the Shanxi Government Sanjintong Mini Program "Antipyretic Drug Sales Registration Information System", Register the drug-related information to ensure that the registered information is complete, true and effective.
At the same time, the province’s drug sales monitoring sentinel pharmacies continue to monitor the sales of cough, antiviral, and antibiotic drugs other than antipyretic drugs, and upload data in real time.
In case of special circumstances, they will continue to monitor the sales of cough, antiviral, and antibiotic drugs.
Report to the epidemic prevention and control office at the same level at once.
In case of special circumstances, they will continue to monitor the sales of cough, antiviral, and antibiotic drugs.
Report to the epidemic prevention and control office at the same level at once.
These behaviors in pharmacies must be strictly investigated
The "Notice" also mentioned that the municipalities and comprehensive reform district bureaus should strengthen supervision, supervise and guide drug retail companies in their jurisdictions to register in a timely manner and use the antipyretic drug sales information registration system to ensure that the suspension of antipyretic drug sales control measures are lifted and the antipyretic drug sales information The registration work is seamless, and we are determined to be a mature family and let go of one family.
In addition, the municipalities and comprehensive reform district bureaus must include the supervision and inspection of the registration of antipyretic drug sales information of pharmaceutical retail enterprises in their jurisdictions as the focus of the annual supervision work, and severely investigate and deal with the registration and sales requirements that are found during the inspection.
It should be noted that in addition to strict inspections on the sales of antipyretic drugs in Shanxi Province this year, these aspects also need to be paid attention to.
According to the Shanxi Province "Notice on Printing and Distributing the Provincial Drug Circulation Supervision and Inspection Work Plan in 2021" (hereinafter referred to as the "Shanxi Province Inspection Plan"), retail pharmacies should focus on these behaviors.
According to the Shanxi Province "Notice on Printing and Distributing the Provincial Drug Circulation Supervision and Inspection Work Plan in 2021" (hereinafter referred to as the "Shanxi Province Inspection Plan"), retail pharmacies should focus on these behaviors.
Shanxi Province’s inspection plan is clear.
Each municipal bureau is responsible for organizing compliance inspections of pharmaceutical retail companies within its jurisdiction.
The number of companies inspected is not less than one-third of the total number of enterprises within its jurisdiction.
Newly established companies in the previous year are included in the supervision and inspection plan for this year.
Each municipal bureau is responsible for organizing compliance inspections of pharmaceutical retail companies within its jurisdiction.
The number of companies inspected is not less than one-third of the total number of enterprises within its jurisdiction.
Newly established companies in the previous year are included in the supervision and inspection plan for this year.
Pharmaceutical retail companies focus on prescription drugs, Chinese herbal medicines, and cold chain drugs.
Based on compliance inspections, they focus on purchasing drugs and recycling drugs through illegal channels; selling drugs beyond the scope of business; failing to store and transport drugs in accordance with regulations , Conduct temperature and humidity monitoring, tamper with computer system, temperature and humidity monitoring system data, conceal real drug purchase and sales records, bills, vouchers, and data; investigate illegal behaviors such as non-compliance of prescription drug sales and "certification" of licensed pharmacists.
Based on compliance inspections, they focus on purchasing drugs and recycling drugs through illegal channels; selling drugs beyond the scope of business; failing to store and transport drugs in accordance with regulations , Conduct temperature and humidity monitoring, tamper with computer system, temperature and humidity monitoring system data, conceal real drug purchase and sales records, bills, vouchers, and data; investigate illegal behaviors such as non-compliance of prescription drug sales and "certification" of licensed pharmacists.
Selling drugs online, focusing on 7 behaviors
In addition, the Shanxi Provincial Inspection Plan also talked about four special inspections, namely, special rectification of drug business behaviors and "certification" of licensed pharmacists, and special rectification of non-compliance in the sales of prescription drugs; special rectification of Chinese herbal medicine pieces; special rectification of online sales of drugs ; Special rectification.
At the beginning of this month, the "Notice on Launching Special Rectification of Drug Online Sales Violations" issued by the Shanxi Provincial Drug Administration pointed out that the requirements of the 2021 provincial drug supervision and management work conference will be fully implemented, and the quality and safety of online sales of drugs will be ensured.
According to the characteristics of drug network sales , we will continue to carry out in-depth special rectification for key links and key enterprises .
According to the characteristics of drug network sales , we will continue to carry out in-depth special rectification for key links and key enterprises .
According to the requirements, the key points of rectification include:
(1) Failing to obtain qualifications to carry out online drug sales, focusing on the following behaviors:
1.
Units that have not obtained the qualification for drug production, operation and use or the qualification exceeds the validity period to illegally engage in drug online pharmnet.
com.
cn/news/yyzb/" target="_blank">procurement and sales activities;
Units that have not obtained the qualification for drug production, operation and use or the qualification exceeds the validity period to illegally engage in drug online pharmnet.
com.
cn/news/yyzb/" target="_blank">procurement and sales activities;
2.
Engaged in providing drug network information services and publishing false drug information without obtaining or exceeding the validity period of the "Internet Drug Information Service Qualification Certificate".
Engaged in providing drug network information services and publishing false drug information without obtaining or exceeding the validity period of the "Internet Drug Information Service Qualification Certificate".
(2) Drug online sellers sell drugs illegally and illegally through the Internet, and focus on the following behaviors:
1.
Illegal sales of counterfeit and inferior drugs, and drugs that have been requested to be recalled or the regulatory authorities have requested to stop the sale of drugs;
Illegal sales of counterfeit and inferior drugs, and drugs that have been requested to be recalled or the regulatory authorities have requested to stop the sale of drugs;
2.
Illegal sales of vaccines, blood products, narcotic drugs, psychotropic drugs, medical toxic drugs, radioactive drugs, pharmaceutical precursor chemicals, and other drugs subject to special management by the state;
Illegal sales of vaccines, blood products, narcotic drugs, psychotropic drugs, medical toxic drugs, radioactive drugs, pharmaceutical precursor chemicals, and other drugs subject to special management by the state;
3.
Failure to sell compound preparations containing ephedrine, codeine, tramadol and other special drugs as required;
Failure to sell compound preparations containing ephedrine, codeine, tramadol and other special drugs as required;
4.
Illegal sales of Chinese medicine formula granules and preparations from medical institutions;
Illegal sales of Chinese medicine formula granules and preparations from medical institutions;
5.
Dealing in drugs beyond the scope and method;
Dealing in drugs beyond the scope and method;
6.
Failure to strictly implement the relevant regulations on the classification management of prescription drugs and non-prescription drugs , and sell prescription drugs without a prescription or without review by a licensed pharmacist;
Failure to strictly implement the relevant regulations on the classification management of prescription drugs and non-prescription drugs , and sell prescription drugs without a prescription or without review by a licensed pharmacist;
7.
The distribution of medicines does not comply with the relevant regulations such as the "Pharmaceutical Operation Quality Management Practice"
The distribution of medicines does not comply with the relevant regulations such as the "Pharmaceutical Operation Quality Management Practice"
(3) The third-party platform for online trading services should focus on the following behaviors:
1.
Whether the third-party platform provider strictly fulfills the qualification review obligations of drug online sellers stationed on the platform;
Whether the third-party platform provider strictly fulfills the qualification review obligations of drug online sellers stationed on the platform;
2.
Whether the third-party platform provider effectively manages the drug business activities that occur on the platform;
Whether the third-party platform provider effectively manages the drug business activities that occur on the platform;
3.
Whether the third-party platform provider promptly stops the online transaction services of drug online sellers suspected of illegal activities.
Whether the third-party platform provider promptly stops the online transaction services of drug online sellers suspected of illegal activities.
Medical Network News, April 19 Since April 16, pharmacies in Shanxi Province have resumed sales of antipyretic drugs.
With immediate effect, pharmacies resume sales
According to the "Notice on Strictly Implementing the Requirements for Suspending the Sale of Antipyretic Drugs During the Period of Epidemic Prevention and Control" issued by the Shanxi Provincial Food and Drug Administration at the beginning of this year, retail pharmacies should immediately suspend the sale of antipyretic drugs to the public after receiving the notice, and make an inventory.
Off the shelf.
Off the shelf.
Today, sales of antipyretic drugs in retail pharmacies in Shanxi Province have finally recovered.
On April 15, the Shanxi Provincial Drug Administration issued the "Notice on Lifting the Control Measures for the Suspension of Sales of Antipyretic Drugs" (hereinafter referred to as the "Notice").
On April 15, the Shanxi Provincial Drug Administration issued the "Notice on Lifting the Control Measures for the Suspension of Sales of Antipyretic Drugs" (hereinafter referred to as the "Notice").
According to the "Notice", according to the requirements of the "Response of the Office of the Leading Group for the Prevention and Control of the Novel Coronavirus Pneumonia Epidemic of Shanxi Province on Lifting the Suspension of Sales of Antipyretic Drugs", the epidemic prevention and control measures will be dynamically adjusted, starting from April 16, 2021 Since the start, the province’s drug retail companies have lifted the control measures for the suspension of sales of antipyretic drugs.
In accordance with the requirements of the "Notice", retail pharmacies must do a good job in registering the sales information of antipyretic drugs across the province.
When pharmaceutical retail enterprises in the province sell antipyretic drugs (the catalogue in the document of the Shanxi Epidemic Prevention and Control Office [2021] No.
28 is still implemented), they should be listed in the Shanxi Government Sanjintong Mini Program "Antipyretic Drug Sales Registration Information System", Register the drug-related information to ensure that the registered information is complete, true and effective.
When pharmaceutical retail enterprises in the province sell antipyretic drugs (the catalogue in the document of the Shanxi Epidemic Prevention and Control Office [2021] No.
28 is still implemented), they should be listed in the Shanxi Government Sanjintong Mini Program "Antipyretic Drug Sales Registration Information System", Register the drug-related information to ensure that the registered information is complete, true and effective.
At the same time, the province’s drug sales monitoring sentinel pharmacies continue to monitor the sales of cough, antiviral, and antibiotic drugs other than antipyretic drugs, and upload data in real time.
In case of special circumstances, they will continue to monitor the sales of cough, antiviral, and antibiotic drugs.
Report to the epidemic prevention and control office at the same level at once.
In case of special circumstances, they will continue to monitor the sales of cough, antiviral, and antibiotic drugs.
Report to the epidemic prevention and control office at the same level at once.
These behaviors in pharmacies must be strictly investigated
The "Notice" also mentioned that the municipalities and comprehensive reform district bureaus should strengthen supervision, supervise and guide drug retail companies in their jurisdictions to register in a timely manner and use the antipyretic drug sales information registration system to ensure that the suspension of antipyretic drug sales control measures are lifted and the antipyretic drug sales information The registration work is seamless, and we are determined to be a mature family and let go of one family.
In addition, the municipalities and comprehensive reform district bureaus must include the supervision and inspection of the registration of antipyretic drug sales information of pharmaceutical retail enterprises in their jurisdictions as the focus of the annual supervision work, and severely investigate and deal with the registration and sales requirements that are found during the inspection.
It should be noted that in addition to strict inspections on the sales of antipyretic drugs in Shanxi Province this year, these aspects also need to be paid attention to.
According to the Shanxi Province "Notice on Printing and Distributing the Provincial Drug Circulation Supervision and Inspection Work Plan in 2021" (hereinafter referred to as the "Shanxi Province Inspection Plan"), retail pharmacies should focus on these behaviors.
According to the Shanxi Province "Notice on Printing and Distributing the Provincial Drug Circulation Supervision and Inspection Work Plan in 2021" (hereinafter referred to as the "Shanxi Province Inspection Plan"), retail pharmacies should focus on these behaviors.
，，，。
、、，，、；；、、、、，、、、；“”。
，7
，，“”、；；；。
，《》，2021，，，、，。
，：
（），：
1.
pharmnet.
com.
cn/news/yyzb/" target="_blank">、；
pharmnet.
com.
cn/news/yyzb/" target="_blank">、；
2.
《》、。
《》、。
（），：
1.
、，；
、，；
2.
、、、、、、；
、、、、、、；
3.
、、；
、、；
4.
、；
、；
5.
、；
、；
6.
，；
，；
7.
《》。
《》。
（），：
1.
；
；
2.
；
；
3.
。
。
419 416，。
，
， 《》，，，。
，。415，《》（《》）。
《》，《》，，2021416，。
In accordance with the requirements of the "Notice", retail pharmacies must do a good job in registering the sales information of antipyretic drugs across the province.
When pharmaceutical retail enterprises in the province sell antipyretic drugs (the catalogue in the document of the Shanxi Epidemic Prevention and Control Office [2021] No.
28 is still implemented), they should be listed in the Shanxi Government Sanjintong Mini Program "Antipyretic Drug Sales Registration Information System", Register the drug-related information to ensure that the registered information is complete, true and effective.
When pharmaceutical retail enterprises in the province sell antipyretic drugs (the catalogue in the document of the Shanxi Epidemic Prevention and Control Office [2021] No.
28 is still implemented), they should be listed in the Shanxi Government Sanjintong Mini Program "Antipyretic Drug Sales Registration Information System", Register the drug-related information to ensure that the registered information is complete, true and effective.
At the same time, the province’s drug sales monitoring sentinel pharmacies continue to monitor the sales of cough, antiviral, and antibiotic drugs other than antipyretic drugs, and upload data in real time.
In case of special circumstances, they will continue to monitor the sales of cough, antiviral, and antibiotic drugs.
Report to the epidemic prevention and control office at the same level at once.
In case of special circumstances, they will continue to monitor the sales of cough, antiviral, and antibiotic drugs.
Report to the epidemic prevention and control office at the same level at once.
These behaviors in pharmacies must be strictly investigated
These behaviors in pharmacies must be strictly investigated The "Notice" also mentioned that the municipalities and comprehensive reform district bureaus should strengthen supervision, supervise and guide drug retail companies in their jurisdictions to register in a timely manner and use the antipyretic drug sales information registration system to ensure that the suspension of antipyretic drug sales control measures are lifted and the antipyretic drug sales information The registration work is seamless, and we are determined to be a mature family and let go of one family.
In addition, the municipalities and comprehensive reform district bureaus must include the supervision and inspection of the registration of antipyretic drug sales information of pharmaceutical retail enterprises in their jurisdictions as the focus of the annual supervision work, and severely investigate and deal with the registration and sales requirements that are found during the inspection.
It should be noted that in addition to strict inspections on the sales of antipyretic drugs in Shanxi Province this year, these aspects also need to be paid attention to.
According to the Shanxi Province "Notice on Printing and Distributing the Provincial Drug Circulation Supervision and Inspection Work Plan in 2021" (hereinafter referred to as the "Shanxi Province Inspection Plan"), retail pharmacies should focus on these behaviors.
According to the Shanxi Province "Notice on Printing and Distributing the Provincial Drug Circulation Supervision and Inspection Work Plan in 2021" (hereinafter referred to as the "Shanxi Province Inspection Plan"), retail pharmacies should focus on these behaviors.
Shanxi Province’s inspection plan is clear.
Each municipal bureau is responsible for organizing compliance inspections of pharmaceutical retail companies within its jurisdiction.
The number of companies inspected is not less than one-third of the total number of enterprises within its jurisdiction.
Newly established companies in the previous year are included in the supervision and inspection plan for this year.
Each municipal bureau is responsible for organizing compliance inspections of pharmaceutical retail companies within its jurisdiction.
The number of companies inspected is not less than one-third of the total number of enterprises within its jurisdiction.
Newly established companies in the previous year are included in the supervision and inspection plan for this year.
Pharmaceutical retail companies focus on prescription drugs, Chinese herbal medicines, and cold chain drugs.
Based on compliance inspections, they focus on purchasing drugs and recycling drugs through illegal channels; selling drugs beyond the scope of business; failing to store and transport drugs in accordance with regulations , Conduct temperature and humidity monitoring, tamper with computer system, temperature and humidity monitoring system data, conceal real drug purchase and sales records, bills, vouchers, and data; investigate illegal behaviors such as non-compliance of prescription drug sales and "certification" of licensed pharmacists.
Based on compliance inspections, they focus on purchasing drugs and recycling drugs through illegal channels; selling drugs beyond the scope of business; failing to store and transport drugs in accordance with regulations , Conduct temperature and humidity monitoring, tamper with computer system, temperature and humidity monitoring system data, conceal real drug purchase and sales records, bills, vouchers, and data; investigate illegal behaviors such as non-compliance of prescription drug sales and "certification" of licensed pharmacists.
Selling drugs online, focusing on 7 behaviors
Selling drugs online, focusing on 7 behaviors In addition, the Shanxi Provincial Inspection Plan also talked about four special inspections, namely, special rectification of drug business behaviors and "certification" of licensed pharmacists, and special rectification of non-compliance in the sales of prescription drugs; special rectification of Chinese herbal medicine pieces; special rectification of online sales of drugs ; Special rectification.
Medicine, medicine, medicine At the beginning of this month, the "Notice on Launching Special Rectification of Drug Online Sales Violations" issued by the Shanxi Provincial Drug Administration pointed out that the requirements of the 2021 provincial drug supervision and management work conference will be fully implemented, and the quality and safety of online sales of drugs will be ensured.
According to the characteristics of drug network sales , we will continue to carry out in-depth special rectification for key links and key enterprises .
Enterprise business enterpriseAccording to the characteristics of drug network sales , we will continue to carry out in-depth special rectification for key links and key enterprises .
According to the requirements, the key points of rectification include:
According to the requirements, the key points of rectification include: (1) Failing to obtain qualifications to carry out online drug sales, focusing on the following behaviors:
1.
Units that have not obtained the qualification for drug production, operation and use or the qualification exceeds the validity period to illegally engage in drug online pharmnet.
com.
cn/news/yyzb/" target="_blank">procurement and sales activities;
pharmnet. Units that have not obtained the qualification for drug production, operation and use or the qualification exceeds the validity period to illegally engage in drug online pharmnet.
com.
cn/news/yyzb/" target="_blank">procurement and sales activities;
com.
cn/news/yyzb/" target="_blank">Procurementpharmnet.
com.
cn/news/yyzb/" target="_blank"> Procurement Procurement
2.
Engaged in providing drug network information services and publishing false drug information without obtaining or exceeding the validity period of the "Internet Drug Information Service Qualification Certificate".
Engaged in providing drug network information services and publishing false drug information without obtaining or exceeding the validity period of the "Internet Drug Information Service Qualification Certificate".
(2) Drug online sellers sell drugs illegally and illegally through the Internet, and focus on the following behaviors:
1.
Illegal sales of counterfeit and inferior drugs, and drugs that have been requested to be recalled or the regulatory authorities have requested to stop the sale of drugs;
Illegal sales of counterfeit and inferior drugs, and drugs that have been requested to be recalled or the regulatory authorities have requested to stop the sale of drugs;
2.
Illegal sales of vaccines, blood products, narcotic drugs, psychotropic drugs, medical toxic drugs, radioactive drugs, pharmaceutical precursor chemicals, and other drugs subject to special management by the state;
Illegal sales of vaccines, blood products, narcotic drugs, psychotropic drugs, medical toxic drugs, radioactive drugs, pharmaceutical precursor chemicals, and other drugs subject to special management by the state;
3.
Failure to sell compound preparations containing ephedrine, codeine, tramadol and other special drugs as required;
Failure to sell compound preparations containing ephedrine, codeine, tramadol and other special drugs as required;
4.
Illegal sales of Chinese medicine formula granules and preparations from medical institutions;
Illegal sales of Chinese medicine formula granules and preparations from medical institutions;
5.
Dealing in drugs beyond the scope and method;
Dealing in drugs beyond the scope and method;
6.
Failure to strictly implement the relevant regulations on the classification management of prescription drugs and non-prescription drugs , and sell prescription drugs without a prescription or without review by a licensed pharmacist;
Over -the-counter drugs over -the-counter drugs over -the-counter drugsFailure to strictly implement the relevant regulations on the classification management of prescription drugs and non-prescription drugs , and sell prescription drugs without a prescription or without review by a licensed pharmacist;
7.
The distribution of medicines does not comply with the relevant regulations such as the "Pharmaceutical Operation Quality Management Practice"
The distribution of medicines does not comply with the relevant regulations such as the "Pharmaceutical Operation Quality Management Practice"
(3) The third-party platform for online trading services should focus on the following behaviors:
1.
Whether the third-party platform provider strictly fulfills the qualification review obligations of drug online sellers stationed on the platform;
Whether the third-party platform provider strictly fulfills the qualification review obligations of drug online sellers stationed on the platform;
2.
Whether the third-party platform provider effectively manages the drug business activities that occur on the platform;
Whether the third-party platform provider effectively manages the drug business activities that occur on the platform;
3.
Whether the third-party platform provider promptly stops the online transaction services of drug online sellers suspected of illegal activities.
Whether the third-party platform provider promptly stops the online transaction services of drug online sellers suspected of illegal activities.
